Here are five key points:
1. If Alphatec manages to hit the $10.22 price target, the company’s worth will clock in at $40.54 million.
2. This 52-week high indicates Alphatec’s strong momentum and will likely attract investors.
3. Since February, Alphatec stock price has increased 148.81 percent and is uptrending.
4. The company has outperformed the S&P 500 by 135.96 percent.
5. Alphatec will report its earnings on Nov. 1, at which time analysts will weigh in on the stock.
More articles on devices:
6 things to know about the global hip reconstruction devices market
29 spine, orthopedic devices receive FDA 510(k) clearance in August
A pair of respected surgeons commend TranS1®’s AxiaLIF+® approach
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
